The efficacy of evolocumab and other lipid-lowering therapies (LLT) for the management of low density lipoprotein cholesterol (LDL-C): a systematic review and network meta-analysis (NMA)

Autor: Worthy, G., Gandra, S.R., Bridges, I., Worth, G., Dent, R., Cheng, L.I., Forbes, C., Deshpande, S., Ross, J., Kleijnen, J., Stroes, E.S.G.
Zdroj: In Atherosclerosis September 2016 252:e56-e57
Databáze: ScienceDirect
Externí odkaz: